Enerpulse Technologies, Inc. - FORM 8-K - EX-16.1 - EXHIBIT 16.1 - September 10, 2013

Attached files

file filename
8-K - FORM 8-K - Enerpulse Technologies, Inc.v354602_8k.htm
EX-21 - EXHIBIT 21 - Enerpulse Technologies, Inc.v354602_ex21.htm
EX-4.3 - EXHIBIT 4.3 - Enerpulse Technologies, Inc.v354602_ex4-3.htm
EX-4.1 - EXHIBIT 4.1 - Enerpulse Technologies, Inc.v354602_ex4-1.htm
EX-4.4 - EXHIBIT 4.4 - Enerpulse Technologies, Inc.v354602_ex4-4.htm
EX-4.5 - EXHIBIT 4.5 - Enerpulse Technologies, Inc.v354602_ex4-5.htm
EX-4.2 - EXHIBIT 4.2 - Enerpulse Technologies, Inc.v354602_ex4-2.htm
EX-4.6 - EXHIBIT 4.6 - Enerpulse Technologies, Inc.v354602_ex4-6.htm
EX-2.1 - EXHIBIT 2.1 - Enerpulse Technologies, Inc.v354602_ex2-1.htm
EX-3.4 - EXHIBIT 3.4 - Enerpulse Technologies, Inc.v354602_ex3-4.htm
EX-10.5 - EXHIBIT 10.5 - Enerpulse Technologies, Inc.v354602_ex10-5.htm
EX-10.3 - EXHIBIT 10.3 - Enerpulse Technologies, Inc.v354602_ex10-3.htm
EX-10.7 - EXHIBIT 10.7 - Enerpulse Technologies, Inc.v354602_ex10-7.htm
EX-10.1 - EXHIBIT 10.1 - Enerpulse Technologies, Inc.v354602_ex10-1.htm
EX-10.2 - EXHIBIT 10.2 - Enerpulse Technologies, Inc.v354602_ex10-2.htm
EX-10.6 - EXHIBIT 10.6 - Enerpulse Technologies, Inc.v354602_ex10-6.htm
EX-10.8 - EXHIBIT 10.8 - Enerpulse Technologies, Inc.v354602_ex10-8.htm
EX-10.4 - EXHIBIT 10.4 - Enerpulse Technologies, Inc.v354602_ex10-4.htm
EX-99.1(A) - EXHIBIT 99.1(A) - Enerpulse Technologies, Inc.v354602_ex99-1a.htm
EX-10.13 - EXHIBIT 10.13 - Enerpulse Technologies, Inc.v354602_ex10-13.htm
EX-10.11 - EXHIBIT 10.11 - Enerpulse Technologies, Inc.v354602_ex10-11.htm
EX-99.1(B) - EXHIBIT 99.1(B) - Enerpulse Technologies, Inc.v354602_ex99-1b.htm
EX-10.14 - EXHIBIT 10.14 - Enerpulse Technologies, Inc.v354602_ex10-14.htm
EX-10.12 - EXHIBIT 10.12 - Enerpulse Technologies, Inc.v354602_ex10-12.htm
EX-10.10 - EXHIBIT 10.10 - Enerpulse Technologies, Inc.v354602_ex10-10.htm
EX-10.9 - EXHIBIT 10.9 - Enerpulse Technologies, Inc.v354602_ex10-9.htm

 

Exhibit 16.1

 

 

L2 Medical Development Company

File No. 000-54092

Form 8-K

 

September 10, 2013

 

U. S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549-2001

 

Gentlemen:

 

On September 10, 2013, this Firm received a copy of a Form 8-K to be filed with the Commission by L2 Medical Development Company (SEC File # 000-54092, CIK: 1495899 (Company) reporting an Item 4.01 - Changes in Registrant’s Certifying Public Accountant.

 

We have no disagreements with the statements made in the Form 8-K,  Item 4.01 disclosures which we read and consent that this letter may be filed as an exhibit to the registrant's Form 8-K.

 

Yours truly,

 

/s/ Goldman Accounting Services CPA, PLLC  
Goldman Accounting Services CPA, PLLC  
Suffern, NY  

 

 

 

Enerpulse Technologies, Inc. Reports